# Expanded Access to ABBV-CLS-484

> **NCT06188975** · — · AVAILABLE · sponsor: **Calico Life Sciences LLC**

## Conditions studied

- Advanced Solid Tumor Cancer

## Interventions

- **DRUG:** DRUG: ABBV-CLS-484

## Key facts

- **NCT ID:** NCT06188975
- **Lead sponsor:** Calico Life Sciences LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188975, "Expanded Access to ABBV-CLS-484". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06188975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*